227 related articles for article (PubMed ID: 2037370)
1. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G.
Cutler CW; Kalmar JR; Arnold RR
Infect Immun; 1991 Jun; 59(6):2097-104. PubMed ID: 2037370
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
Cutler CW; Kalmar JR; Arnold RR
Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
Cutler CW; Arnold RR; Schenkein HA
J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
[TBL] [Abstract][Full Text] [Related]
4. Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes.
Fan Q; Sims T; Sojar H; Genco R; Page RC
Oral Microbiol Immunol; 2001 Jun; 16(3):144-52. PubMed ID: 11358536
[TBL] [Abstract][Full Text] [Related]
5. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis.
Nakagawa T; Sims T; Fan Q; Potempa J; Travis J; Houston L; Page RC
Oral Microbiol Immunol; 2001 Aug; 16(4):202-11. PubMed ID: 11442844
[TBL] [Abstract][Full Text] [Related]
6. Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing.
Genco CA; Schifferle RE; Njoroge T; Forng RY; Cutler CW
Infect Immun; 1995 Feb; 63(2):393-401. PubMed ID: 7822002
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis.
Genco CA; Cutler CW; Kapczynski D; Maloney K; Arnold RR
Infect Immun; 1991 Apr; 59(4):1255-63. PubMed ID: 2004807
[TBL] [Abstract][Full Text] [Related]
8. Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case: control study.
Wilton JM; Hurst TJ; Sterne JA
J Clin Periodontol; 1993 Sep; 20(8):563-9. PubMed ID: 8408718
[TBL] [Abstract][Full Text] [Related]
9. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis.
Saito S; Hayakawa M; Takiguchi H; Abiko Y
J Periodontol; 1999 Jun; 70(6):610-7. PubMed ID: 10397516
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.
Guentsch A; Puklo M; Preshaw PM; Glockmann E; Pfister W; Potempa J; Eick S
J Periodontal Res; 2009 Jun; 44(3):368-77. PubMed ID: 19210340
[TBL] [Abstract][Full Text] [Related]
11. Influence of immunization on Porphyromonas gingivalis colonization and invasion in the mouse chamber model.
Genco CA; Kapczynski DR; Cutler CW; Arko RJ; Arnold RR
Infect Immun; 1992 Apr; 60(4):1447-54. PubMed ID: 1312515
[TBL] [Abstract][Full Text] [Related]
12. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.
Wilson ME; Bronson PM; Hamilton RG
Infect Immun; 1995 Mar; 63(3):1070-5. PubMed ID: 7868229
[TBL] [Abstract][Full Text] [Related]
14. Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis.
Gibson FC; Savelli J; Van Dyke TE; Genco CA
J Periodontol; 2005 Oct; 76(10):1629-36. PubMed ID: 16253083
[TBL] [Abstract][Full Text] [Related]
15. Ingestion of Bacteroides buccae, Bacteroides oris, Porphyromonas gingivalis, and Fusobacterium nucleatum by human polymorphonuclear leukocytes in vitro.
Kerosuo E; Haapasalo M; Alli K; Lounatmaa K
Oral Microbiol Immunol; 1990 Aug; 5(4):202-7. PubMed ID: 2082243
[TBL] [Abstract][Full Text] [Related]
16. Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis.
Sjöström K; Darveau R; Page R; Whitney C; Engel D
Infect Immun; 1992 Nov; 60(11):4819-25. PubMed ID: 1398993
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis of Porphyromonas gingivalis and Prevotella intermedia by human polymorphonuclear leukocytes in clots formed from human plasma or purified fibrinogen.
Hurst TJ; Wilton JM
J Periodontal Res; 1992 Mar; 27(2):111-8. PubMed ID: 1312590
[TBL] [Abstract][Full Text] [Related]
18. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
19. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
[TBL] [Abstract][Full Text] [Related]
20. Effects of anaerobiosis and aerobiosis on interactions of human polymorphonuclear leukocytes with the dental plaque bacteria Streptococcus mutans, Capnocytophaga ochracea, and Bacteroides gingivalis.
Thompson HL; Wilton JM
Infect Immun; 1991 Mar; 59(3):932-40. PubMed ID: 1847699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
